Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Special : Fruitflow and its relationship with Covid-19 with Prof. Asim Duttaroy (inventor of Fruitflow), Ruedi Duss, Taichi Inui, Ernest Prayuda
https://www.facebook.com/LifeScience.co.id/videos/795458058000152/?__cft__[0]=AZVq1jnnS4msUxA-stIxtwub1-y_ql5C5awc-yHN5QtpstLtQpLmbUZwmfNm6VjXzlIRnABVk80HHzt2h6U6WeguoD4_1M9fGRQmpoWkgqVTUOOy80OVmjM_HJlzTzmXMdKDvaQUZBboFAFxCFvYWcvnMktldfjoJkZcRemiYg6LSw&__tn__=%2CO%2CP-R
You can skip the first 35 min
Now on YouTube
https://youtu.be/OBD7jv7IMBI
Thanks gix for link. This is potentially huge news. What I don’t understand, maybe you can help me:
- why is this not being shouted from the roof tops. Neither PXS/ DSM/ ByHealth are talking about this. Not that I have seen anyway. When I say huge I mean really huge, you are talking about a potential game changer in one of the biggest events in history right now.
- Out of all platforms, why is Asim talking about FF/ Covid on this random small AFC YouTube channel. Who are they, they have like 70 subscribers. I just don’t understand the plan of action here.
- Simply, what is going on guys. Like there is no way a product like this, even before covid it’s potential was huge, feels like it’s been buried. Now with covid it’s potential is just for up 10x more. And still nothing. I just can’t imagine that DSM are sitting on this. Let’s say they are not, ok, but then where is the big launches, where is the proper money trickling down to PXS. I can’t imagine large pharma/ Corps are not wanting to add this to their products. This is the biggest opportunity for any health products right now, especially FF. And all is silent. Just doesn’t make sense.
I still hold, I still read, I still hope, I still wonder...but this is crazy.
Not a peep from pxs either these days.
GL all
"why is this not being shouted from the roof tops"
Good question, but without proof PXS/DSM could end up in hot water for what could be considered as false claims.
Its pretty obvious, to me anyway, that from this video and the recent publication shows that work is going on in the background to link the benefits of Fruitflow to helping with the severity of Covid-19. At one point in the video Duttaroy says "you will see, later on in my paper, will be coming soon" (1:35:45) so it looks like there maybe more scientific publications (or other) to follow.
Of coarse we could spend millions of pounds on full scale clinical trials to prove the benefits of Fruitflow on Covid but........
AIMO DYOR etc. etc.
Hi Gixer. Not scheduled time in the watch the video yet, nice find.
Does it talk only of prevention, or is there any discussion of using FF for long covid?
Website updated. https://www.provexis.com/?news=fruitflow-and-its-relationship-with-covid-19-afc-lifescience-sop-subarashi
Barbershop, Its worth listening to but the majority of the video is taken up by all the stuff we already know.
The Covid related section is at the end around 1:15 and would recommend listening to that.
No mention of long covid that I noticed.
http://postimg.cc/rRKFsGqc
We've know for a long time now that Fruitflow addresses one of the worst consequences of Covid, sticky blood. The logical conclusion is that daily use would be beneficial in alleviating suffering. It's no surprise that Dr Asim will release medical papers, and publication will further enhance the value of the IP. However, for Provexis to commercialise the IP would involve many hurdles, as have each of the other health claims. Almost taking us back to square one. If some new investors see this as a medium/long term risk, the sp may respond accordingly. Seeing increased revenues from the current IP, especially reaching self sustaining status, would have a much stronger effect IMHO
it would be good if all the links on the news page had a short description/summary of what the linked presentation is all about and why the link has been posted, including context
the title
Fruitflow® and its relationship with COVID-19: AFC LifeScience, SOP Subarashi
Really doesn't inform the reader or encourage anyone to view the link
-- sloppy imo
W$
It's a minefield though isn't it.
Who's to say there will be any commercial benefit from a medical paper still to be published?
I know you could point to other companies that have done just that, some of whom stretch market abuse rules
I'd like to see more definitive points from the paper when it's public knowledge, and at that point PXS/DSM to explain how that affects prospects for the IP.
Not before.
The good thing is that AFC are willing to promote "Fruitflow and its relationship with Covid-19". It all helps to get the message out.
Gixer thank you for all your research I really appreciate it (-: